TRIB

Q: What is the price of Trinity Biotech (TRIB) today?

The price of Trinity Biotech (TRIB) today is $ 0.72, with return of -2.43% compared to the last year. The price of Trinity Biotech (TRIB) started the year trading around $ 0.79 and today it is at $ 0.72. Follow the real-time price chart, the historical price of Trinity Biotech (TRIB) and international markets.

Q: When does Trinity Biotech (TRIB) pay dividends?

Trinity Biotech (TRIB) did not distribute dividends in the last year.

Q: Is Trinity Biotech (TRIB) worth it?

Currently, Trinity Biotech (TRIB) is priced at $ 0.72, with a P/E of -0.45%, representing a deviation of -898% from its historical average P/E. In the last year, the stock showed a variation of -2.43 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -2.43%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Trinity Biotech (TRIB) stock?

Investing in stocks of Trinity Biotech (TRIB) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Trinity Biotech (TRIB) yield today?

The yield of Trinity Biotech (TRIB) was -10.00% in the last month, -2.43% in the last year and -96.90% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Trinity Biotech (TRIB) today, the total investment would be $ 72.00, based on the current price of $ 0.72.If past performance were to repeat, the return on your investment would be:In 1 year: $ 70.25In 5 years: $ 2.23In 10 years: $ 0.91It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Trinity Biotech PLC

Price

$ 0.72

return (12m)

-2.43%

p/e

-0.45

p/bv

-0.26

DIVIDEND YIELD

0.00%

TRIB price

TRIB

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TRIB

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.00%

3 months

-32.71%

1 year

-2.43%

2 years

-67.71%

5 years

-96.90%

10 years

-98.74%

Fundamentals TRIB

review the fundamentals of Trinity Biotech shares

P/E

-0.45

Sector: -1.76 Industry: -5.09

P/S (PSR)

0.29

Sector: 1.97 Industry: 3.06

P/BV

-0.26

Sector: 2.25 Industry: 2.50

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-29.33%

Sector: -26.80% Industry: -51.83%

ROE

58.98%

Sector: -30.41% Industry: -44.07%

ROIC

0.00%

Sector: -421.51% Industry: -486.27%

NET MARGIN

-64.75%

Sector: -29.02% Industry: -34.94%

GROSS MARGIN

33.64%

Sector: 44.34% Industry: 46.39%

OPERATING MARGIN

-30.40%

Sector: -24.67% Industry: -30.68%

EV/EBITDA

-0.76

Sector: -0.69 Industry: -3.98

EV/EBIT

-0.72

Sector: -2.84 Industry: -5.84

PRICE-TO-ASSETS

0.13

Sector: 1.19 Industry: 1.41

BVPS

-2.75

Sector: 3.50 Industry: 1.70

EPS

-1.62

Sector: -0.89 Industry: -1.30

EQUITY-TO-ASSETS RATIO

-0.50

Sector: 0.43 Industry: 0.46

LIABILITIES / ASSETS

1.50

Sector: 0.46 Industry: 0.43

CAGR REVENUE 5 YEARS

-0.11%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

70.18%

Sector: - Industry: -

Fundamentals TRIB

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	42.95	37.16	86.53%	0.61%	$ 886.35 B	31.66%
ISRG	60.93	9.70	15.92%	0.00%	$ 174.01 B	28.38%
TMO	28.15	3.53	12.52%	0.34%	$ 188.74 B	15.05%
SNY	11.92	1.30	10.86%	4.97%	$ 108.75 B	18.68%
NVS	21.93	6.59	30.04%	2.42%	$ 306.63 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	25.28	2.37	9.38%	3.11%	$ 116.62 B	13.00%
CVS	55.97	1.31	2.35%	3.41%	$ 98.96 B	0.44%
GSK	14.25	5.09	35.71%	3.08%	$ 108.69 B	17.48%
BSX	36.51	0.00	0.00%	0.00%	$ 105.81 B	14.44%
TMDX	23.16	9.31	40.22%	0.00%	$ 4.41 B	31.43%
HCA	17.91	-43.84	-244.82%	0.54%	$ 121.48 B	8.97%
IDXX	45.94	30.32	65.99%	0.00%	$ 48.67 B	24.62%
RMD	24.79	5.83	23.51%	0.90%	$ 36.83 B	27.53%
DHR	38.25	2.63	6.88%	0.65%	$ 138.22 B	14.71%
INMD	8.88	1.22	13.73%	0.00%	$ 833.49 M	25.32%
PHG	26.52	2.14	8.06%	3.06%	$ 27.51 B	5.07%
FMS	11.63	0.78	6.75%	3.43%	$ 13.13 B	5.02%
SYK	43.01	6.23	14.48%	0.93%	$ 139.63 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TRIB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	06/09/2015	07/01/2015	1,10000000
Dividend	06/10/2014	07/01/2014	1,10000000
Dividend	06/10/2013	07/01/2013	1,00000000
Dividend	06/08/2012	06/22/2012	0,75000000
Dividend	06/09/2011	06/23/2011	2,00000000

ABOUT Trinity Biotech

Trinity Biotech PLC

Average Investor10 user rating

4.0 (0 people)

United States

34 years

Founded: 1992

1992

Time since IPO - 34 years

543

Employees

The Company Trinity Biotech PLC (United States), is listed on Nasdaq with a market value of $ 13.12 Millions, having an equity of $ -49.54 Millions.

With a total of 543 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 45.13 Millions, which generated a loss in the amount of $ -29.22 Millions.

As for its main indicators, the Company has a P/E ratio of -0.45, a P/BV ratio of -0.26 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TRIB.

Market cap

$ 13.12 Millions

Net worth

$ -49.54 Millions

US$ -49,540,000.00

Assets

$ 99.63 Millions

US$ 99,630,000.00

Total Shares Outstanding

18.00 Millions

18,000,000

Average Daily Trading Volume

$ 3.95 Millions

US$ 3,949,058.00

Sector

Health

Industry

Medical Supplies and Equipment

TRIB

TRIB revenue and profits

Financial Results TRIB

DRAG THE FRAME TO SEE MORE DATA

TRIB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 75.72 21,23% (12M)

P/E

55.97

3.41%

ROE

2.35%

P/BV

1.31

CI - Cigna

$ 260.87 --13,94% (12M)

P/E

10.52

2.22%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.86 --38,65% (12M)

P/E

-3.22

0.00%

ROE

-33.28%

P/BV

1.07

HUM - Humana

$ 170.95 --30,07% (12M)

P/E

18.10

1.98%

ROE

6.70%

P/BV

1.21

HCA - HCA Healthcare

$ 537.28 73,29% (12M)

P/E

17.91

0.54%

ROE

-244.82%

P/BV

-43.84

LLY - Eli Lilly

$ 999.84 25,63% (12M)

P/E

42.95

0.61%

ROE

86.53%

P/BV

37.16

NVS - Novartis

$ 155.80 50,86% (12M)

P/E

21.93

2.42%

ROE

30.04%

P/BV

6.59